Home › Funds › Omega Fund Management, LLC › NUVB

Omega Fund Management, LLC position in NUVB

NUVATION BIO INC · Health Care

Omega Fund Management, LLC reported holding 7,151,031 shares of NUVB (NUVATION BIO INC) in its Q3 2026 13F filing — a position valued at US$40.0M, representing 31.99% of its reported portfolio and ranking #1 among its reported holdings. Omega Fund Management, LLC has disclosed NUVB holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)7.15M sh
Reported value held$40.05M
Portfolio Weight31.99%
First reportedQ3 2023
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Omega Fund Management, LLC's NUVB position evolved

Omega Fund Management, LLC first disclosed a stake in NUVB in Q3 2023 at 15,072,340 shares (US$20.2M). The position peaked in Q4 2025 at 8,081,089 shares, worth US$72.4M. Across 13 filings, Omega Fund Management, LLC increased the stake 0 time(s), trimmed it 7 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 7,151,031 shares valued at US$40.0M — a reduction of -930,058 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 15.07M $20.20M New
Q4 2023 15.07M $22.76M Hold
Q1 2024 14.07M $51.22M Reduce
Q2 2024 13.28M $38.77M Reduce
Q3 2024 13.07M $29.94M Reduce
Q4 2024 13.07M $34.77M Hold
Q1 2025 13.07M $23.01M Hold
Q2 2025 11.04M $21.53M Reduce
Q3 2025 8.83M $32.68M Reduce
Q4 2025 8.08M $72.41M Reduce
Q1 2026 8.08M $34.67M Hold
Q2 2026 8.08M $45.90M Hold
Q3 2026 7.15M $40.05M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NUVB and 13F data

NUVB (NUVATION BIO INC) is a Health Care company. 54 other funds we track also report a position in NUVB — the largest reported positions include Decheng Capital LLC (US$145.3M), Context Capital Management, LLC (US$53.1M), Laurion Capital Management LP (US$43.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NUVB

All NUVB fund holders →

FAQ

How long has Omega Fund Management, LLC held NUVB?

Omega Fund Management, LLC has disclosed NUVB holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Omega Fund Management, LLC's current position in NUVB?

As of Q3 2026, Omega Fund Management, LLC holds 7.15M shares of NUVB (NUVATION BIO INC), valued at $40.05M, representing 31.99% of its reported portfolio and ranking #1.

Has Omega Fund Management, LLC been buying or selling NUVB?

In the latest 13F filing (Q3 2026), Omega Fund Management, LLC reduced its position in NUVB. The position peaked in Q4 2025 at 8.08M shares.

Which other funds hold NUVB?

Other major institutional holders of NUVB include Decheng Capital LLC, Context Capital Management, LLC, Laurion Capital Management LP, among 54 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.